> top > docs > PubMed:24687378 > annotations

PubMed:24687378 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-80 Sentence denotes MRI breast screening in high-risk women: cancer detection and survival analysis.
TextSentencer_T2 81-243 Sentence denotes Women with a genetic predisposition to breast cancer tend to develop the disease at a younger age with denser breasts making mammography screening less effective.
TextSentencer_T3 244-407 Sentence denotes The introduction of magnetic resonance imaging (MRI) for familial breast cancer screening programs in recent years was intended to improve outcomes in these women.
TextSentencer_T4 408-750 Sentence denotes We aimed to assess whether introduction of MRI surveillance improves 5- and 10-year survival of high-risk women and determine the accuracy of MRI breast cancer detection compared with mammography-only or no enhanced surveillance and compare size and pathology of cancers detected in women screened with MRI + mammography and mammography only.
TextSentencer_T5 751-975 Sentence denotes We used data from two prospective studies where asymptomatic women with a very high breast cancer risk were screened by either mammography alone or with MRI also compared with BRCA1/2 carriers with no intensive surveillance.
TextSentencer_T6 976-1081 Sentence denotes 63 cancers were detected in women receiving MRI + mammography and 76 in women receiving mammography only.
TextSentencer_T7 1082-1146 Sentence denotes Sensitivity of MRI + mammography was 93 % with 63 % specificity.
TextSentencer_T8 1147-1250 Sentence denotes Fewer cancers detected on MRI were lymph node positive compared to mammography/no additional screening.
TextSentencer_T9 1251-1484 Sentence denotes There were no differences in 10-year survival between the MRI + mammography and mammography-only groups, but survival was significantly higher in the MRI-screened group (95.3 %) compared to no intensive screening (73.7 %; p = 0.002).
TextSentencer_T10 1485-1548 Sentence denotes There were no deaths among the 21 BRCA2 carriers receiving MRI.
TextSentencer_T11 1549-1633 Sentence denotes There appears to be benefit from screening with MRI, particularly in BRCA2 carriers.
TextSentencer_T12 1634-1731 Sentence denotes Extended follow-up of larger numbers of high-risk women is required to assess long-term survival.
T1 0-80 Sentence denotes MRI breast screening in high-risk women: cancer detection and survival analysis.
T2 81-243 Sentence denotes Women with a genetic predisposition to breast cancer tend to develop the disease at a younger age with denser breasts making mammography screening less effective.
T3 244-407 Sentence denotes The introduction of magnetic resonance imaging (MRI) for familial breast cancer screening programs in recent years was intended to improve outcomes in these women.
T4 408-750 Sentence denotes We aimed to assess whether introduction of MRI surveillance improves 5- and 10-year survival of high-risk women and determine the accuracy of MRI breast cancer detection compared with mammography-only or no enhanced surveillance and compare size and pathology of cancers detected in women screened with MRI + mammography and mammography only.
T5 751-975 Sentence denotes We used data from two prospective studies where asymptomatic women with a very high breast cancer risk were screened by either mammography alone or with MRI also compared with BRCA1/2 carriers with no intensive surveillance.
T6 976-1081 Sentence denotes 63 cancers were detected in women receiving MRI + mammography and 76 in women receiving mammography only.
T7 1082-1146 Sentence denotes Sensitivity of MRI + mammography was 93 % with 63 % specificity.
T8 1147-1250 Sentence denotes Fewer cancers detected on MRI were lymph node positive compared to mammography/no additional screening.
T9 1251-1484 Sentence denotes There were no differences in 10-year survival between the MRI + mammography and mammography-only groups, but survival was significantly higher in the MRI-screened group (95.3 %) compared to no intensive screening (73.7 %; p = 0.002).
T10 1485-1548 Sentence denotes There were no deaths among the 21 BRCA2 carriers receiving MRI.
T11 1549-1633 Sentence denotes There appears to be benefit from screening with MRI, particularly in BRCA2 carriers.
T12 1634-1731 Sentence denotes Extended follow-up of larger numbers of high-risk women is required to assess long-term survival.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 927-932 gene:672 denotes BRCA1
T1 835-848 disease:C0006142 denotes breast cancer
T2 927-932 gene:672 denotes BRCA1
T3 835-848 disease:C0678222 denotes breast cancer
R1 T0 T1 associated_with BRCA1,breast cancer
R2 T2 T3 associated_with BRCA1,breast cancer

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 120-133 HP_0003002 denotes breast cancer
T2 120-133 HP_0100013 denotes breast cancer
T3 127-133 HP_0002664 denotes cancer
T4 310-323 HP_0003002 denotes breast cancer
T5 310-323 HP_0100013 denotes breast cancer
T6 317-323 HP_0002664 denotes cancer
T7 554-567 HP_0003002 denotes breast cancer
T8 554-567 HP_0100013 denotes breast cancer
T9 561-567 HP_0002664 denotes cancer
T10 671-678 HP_0002664 denotes cancers
T11 835-848 HP_0003002 denotes breast cancer
T12 835-848 HP_0100013 denotes breast cancer
T13 842-848 HP_0002664 denotes cancer
T14 979-986 HP_0002664 denotes cancers
T15 1153-1160 HP_0002664 denotes cancers

Allie

Id Subject Object Predicate Lexical cue
SS1_24687378_2_0 264-290 expanded denotes magnetic resonance imaging
SS2_24687378_2_0 292-295 abbr denotes MRI
AE1_24687378_2_0 SS1_24687378_2_0 SS2_24687378_2_0 abbreviatedTo magnetic resonance imaging,MRI

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
24687378-4#176#181#gene672 927-932 gene672 denotes BRCA1
24687378-4#84#97#diseaseC0006142 835-848 diseaseC0006142 denotes breast cancer
24687378-4#84#97#diseaseC0678222 835-848 diseaseC0678222 denotes breast cancer
176#181#gene67284#97#diseaseC0006142 24687378-4#176#181#gene672 24687378-4#84#97#diseaseC0006142 associated_with BRCA1,breast cancer
176#181#gene67284#97#diseaseC0678222 24687378-4#176#181#gene672 24687378-4#84#97#diseaseC0678222 associated_with BRCA1,breast cancer

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T526 927-932 gene:672 denotes BRCA1
T527 835-848 disease:C0006142 denotes breast cancer
R1 T526 T527 associated_with BRCA1,breast cancer
R2 T526 T527 associated_with BRCA1,breast cancer

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 4-10 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 120-126 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 191-198 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breasts
PD-UBERON-AE-B_T4 310-316 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 554-560 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 835-841 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T7 1182-1187 http://purl.obolibrary.org/obo/UBERON_0002391 denotes lymph
PD-UBERON-AE-B_T8 1182-1192 http://purl.obolibrary.org/obo/UBERON_0000029 denotes lymph node

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 4-10 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T2 120-126 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T3 310-316 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T4 554-560 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T5 835-841 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast
PD-UBERON-AE-B_T6 1182-1187 http://purl.obolibrary.org/obo/UBERON_0002391 denotes lymph
PD-UBERON-AE-B_T7 1182-1192 http://purl.obolibrary.org/obo/UBERON_0000029 denotes lymph node